• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

室温不稳定药物在门诊环境下的储存。

Thermolabile drug storage in an ambulatory setting.

机构信息

Pharmacy Department, Son Espases University Hospital, Cra. de Valldemossa, 79, 07120, Palma, Illes Balears, Spain.

eHealth and Telemedicine Research Group, IdisBa, Cra. Valldemossa, Palma, Illes Balears, Spain.

出版信息

Sci Rep. 2021 Mar 16;11(1):5959. doi: 10.1038/s41598-021-85413-0.

DOI:10.1038/s41598-021-85413-0
PMID:33727627
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7966808/
Abstract

More thermolabile drugs are becoming available, and in most cases, these medications are dispensed to ambulatory patients. However, there is no regulation once medications are dispensed to patients and little is known with regard to what happens during transport and home storage. Previous studies suggest that these drugs are improperly stored. The present study was designed to determine the storage conditions of thermolabile drugs once they are dispensed to the patient in the Hospital Pharmacy Department. This is a prospective observational study to assess the temperature profile of 7 thermolabile drugs once they are dispensed to ambulatory patients at a tertiary care hospital. A data logger was added to the medication packaging. Temperature was considered inappropriate if one of the following circumstances were met: any temperature record less than or equal to 0 °C or over 25 °C; temperatures between 0-2 or 8-25 °C for a continuous period over 30 min. The time series of temperature measurements obtained from each data logger were analyzed as statistically independent variables. The data shown did not undergo any statistical treatment and must be considered directly related to thermal measurements. One hundred and fourteen patients were included and 107 patients were available for the analysis. On the whole, a mean of 50.6 days (SD 18.3) were measured and the mean temperature was 6.88 °C (SD 2.93). Three data loggers (2.8%) maintained all the measurements between 2 and 8 °C with less than 3 continuous data (< 30 min) out of this range but no data over 25 °C or below or equal to 0 °C. 28 (26.2%) data loggers had at least one measurement below zero, 1 data logger had a measurement greater than 25 °C and 75 (70.1%) were between 0 and 2 °C and/or between 8 and 25 °C for more than 30 min. In conclusion, once dispensed to patients, most thermolabile drugs are improperly stored. Future studies should focus on clinical consequences and possible solutions.

摘要

越来越多的热敏药物可供使用,在大多数情况下,这些药物被分发给门诊患者。然而,一旦药物分发给患者,就没有规定,也很少有人知道在运输和家庭储存过程中会发生什么。先前的研究表明,这些药物储存不当。本研究旨在确定热敏药物在医院药房分发给患者后患者的储存条件。这是一项前瞻性观察研究,用于评估在一家三级保健医院分发给门诊患者的 7 种热敏药物的温度情况。在药物包装中添加了一个数据记录器。如果满足以下任何一种情况,则认为温度不合适:任何温度记录等于或小于 0°C 或大于 25°C;在 30 分钟以上的连续时间段内,温度在 0-2 或 8-25°C 之间。从每个数据记录器获得的温度测量时间序列被分析为独立的统计变量。所示数据未经任何统计处理,必须直接与热测量相关。共纳入 114 例患者,107 例患者可进行分析。总体而言,平均测量 50.6 天(SD 18.3),平均温度为 6.88°C(SD 2.93°C)。有 3 个数据记录器(2.8%)将所有测量值保持在 2-8°C 之间,连续数据(<30 分钟)小于 3 次超出此范围,但没有数据超过 25°C 或低于或等于 0°C。28 个(26.2%)数据记录器至少有一次测量值低于零,1 个数据记录器有一次测量值大于 25°C,75 个(70.1%)在 0-2°C 和/或 8-25°C 之间超过 30 分钟。总之,一旦分发给患者,大多数热敏药物储存不当。未来的研究应侧重于临床后果和可能的解决方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ec/7966808/756834786b96/41598_2021_85413_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ec/7966808/15b0e52a5039/41598_2021_85413_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ec/7966808/0638004d3c27/41598_2021_85413_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ec/7966808/186058fd2ec2/41598_2021_85413_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ec/7966808/756834786b96/41598_2021_85413_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ec/7966808/15b0e52a5039/41598_2021_85413_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ec/7966808/0638004d3c27/41598_2021_85413_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ec/7966808/186058fd2ec2/41598_2021_85413_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ec/7966808/756834786b96/41598_2021_85413_Fig4_HTML.jpg

相似文献

1
Thermolabile drug storage in an ambulatory setting.室温不稳定药物在门诊环境下的储存。
Sci Rep. 2021 Mar 16;11(1):5959. doi: 10.1038/s41598-021-85413-0.
2
[Quality of storage of thermolabile drugs in patients' homes].[患者家中热敏性药物的储存质量]
Rev Calid Asist. 2010 Mar-Apr;25(2):64-9. doi: 10.1016/j.cali.2009.09.001. Epub 2009 Nov 1.
3
Effect of a smart temperature logger on correctly storing biological disease-modifying antirheumatic drugs at home: a pre-post study.
Eur J Hosp Pharm. 2024 Dec 30. doi: 10.1136/ejhpharm-2023-004028.
4
Home storage of biological medications administered to patients with rheumatic diseases.风湿疾病患者使用的生物药物的家庭储存。
Adv Rheumatol. 2020 May 27;60(1):30. doi: 10.1186/s42358-020-00131-x.
5
Drugs, dogs, and driving: the potential for year-round thermal stress in UK vehicles.药物、犬只和驾驶:英国车辆全年潜在的热应激问题。
Open Vet J. 2020 Aug;10(2):216-225. doi: 10.4314/ovj.v10i2.11. Epub 2020 Jun 30.
6
Actual versus recommended storage temperatures of oral anticancer medicines at patients' homes.患者家中口服抗癌药物的实际储存温度与推荐储存温度对比。
J Oncol Pharm Pract. 2019 Mar;25(2):382-389. doi: 10.1177/1078155217741767. Epub 2017 Nov 29.
7
The range of medication storage temperatures in aeromedical emergency medical services.空中医疗急救服务中药物储存温度的范围。
Prehosp Emerg Care. 1999 Jan-Mar;3(1):27-30. doi: 10.1080/10903129908958902.
8
Exploring conditions for redistribution of anti-tumor necrosis factors to reduce spillage: A study on the quality of anti-tumor necrosis factor home storage.探索减少溢出的抗肿瘤坏死因子再分配条件:抗肿瘤坏死因子家庭储存质量研究。
J Gastroenterol Hepatol. 2018 Feb;33(2):426-430. doi: 10.1111/jgh.13920.
9
Effect of Extreme Temperature on Naloxone Nasal Spray Dispensing Device Performance.极端温度对纳洛酮鼻喷剂给药装置性能的影响。
Prehosp Disaster Med. 2020 Jun;35(3):272-275. doi: 10.1017/S1049023X20000400. Epub 2020 Apr 13.
10
Storage stability of simulator ethanol solutions for vapor-alcohol control tests in breath-alcohol analysis.用于呼气酒精分析中蒸汽酒精控制测试的模拟器乙醇溶液的储存稳定性。
J Anal Toxicol. 2002 Oct;26(7):406-10. doi: 10.1093/jat/26.7.406.

引用本文的文献

1
How are we handling protein drugs in hospitals? A human factors and systems engineering approach to compare two hospitals and suggest a best practice.医院如何管理蛋白药物?采用人为因素和系统工程学方法比较两家医院并提出最佳实践建议。
Int J Qual Health Care. 2024 Mar 18;36(1). doi: 10.1093/intqhc/mzae020.
2
Fused Deposition Modeling (FDM) 3D Printing of the Thermo-Sensitive Peptidomimetic Drug Enalapril Maleate.马来酸依那普利热敏拟肽药物的熔融沉积成型(FDM)3D打印
Pharmaceutics. 2022 Nov 8;14(11):2411. doi: 10.3390/pharmaceutics14112411.
3
Polymer-Based Nanofiber-Nanoparticle Hybrids and Their Medical Applications.

本文引用的文献

1
Domestic refrigerator temperatures in Spain: Assessment of its impact on the safety and shelf-life of cooked meat products.西班牙国内冰箱温度:评估其对熟肉产品安全性和保质期的影响。
Food Res Int. 2019 Dec;126:108578. doi: 10.1016/j.foodres.2019.108578. Epub 2019 Jul 22.
2
Storage Conditions of Insulin in Domestic Refrigerators and When Carried by Patients: Often Outside Recommended Temperature Range.家用冰箱中胰岛素的储存条件以及患者携带时的情况:经常超出推荐温度范围。
Diabetes Technol Ther. 2019 May;21(5):238-244. doi: 10.1089/dia.2019.0046. Epub 2019 Apr 19.
3
The Impact of Inadequate Temperature Storage Conditions on Aggregate and Particle Formation in Drugs Containing Tumor Necrosis Factor-Alpha Inhibitors.
基于聚合物的纳米纤维-纳米颗粒杂化材料及其医学应用。
Polymers (Basel). 2022 Jan 17;14(2):351. doi: 10.3390/polym14020351.
4
3D Printing of Thermo-Sensitive Drugs.热敏药物的3D打印
Pharmaceutics. 2021 Sep 21;13(9):1524. doi: 10.3390/pharmaceutics13091524.
温度储存条件不足对含肿瘤坏死因子-α抑制剂药物中聚集和颗粒形成的影响。
Pharm Res. 2018 Feb 5;35(2):42. doi: 10.1007/s11095-017-2341-x.
4
Exploring conditions for redistribution of anti-tumor necrosis factors to reduce spillage: A study on the quality of anti-tumor necrosis factor home storage.探索减少溢出的抗肿瘤坏死因子再分配条件:抗肿瘤坏死因子家庭储存质量研究。
J Gastroenterol Hepatol. 2018 Feb;33(2):426-430. doi: 10.1111/jgh.13920.
5
The majority of patients do not store their biologic disease-modifying antirheumatic drugs within the recommended temperature range.大多数患者并未将其生物制剂类改善病情抗风湿药物存放在推荐的温度范围内。
Rheumatology (Oxford). 2016 Apr;55(4):704-9. doi: 10.1093/rheumatology/kev394. Epub 2015 Dec 16.
6
Protein aggregation and its impact on product quality.蛋白质聚集及其对产品质量的影响。
Curr Opin Biotechnol. 2014 Dec;30:211-7. doi: 10.1016/j.copbio.2014.08.001. Epub 2014 Aug 28.
7
[Thermolabile drugs stability faced with an accidental interruption in the cold chain].[面临冷链意外中断时热不稳定药物的稳定性]
Farm Hosp. 2014 May 1;38(3):169-92. doi: 10.7399/fh.2014.38.3.1164.
8
[Quality of storage of thermolabile drugs in patients' homes].[患者家中热敏性药物的储存质量]
Rev Calid Asist. 2010 Mar-Apr;25(2):64-9. doi: 10.1016/j.cali.2009.09.001. Epub 2009 Nov 1.